Prostate Cancer Analysis in Follow-up in the Oncology Care Network of Espírito Santo, Brazil

Introduction: Hospital-based Cancer Registries (HCR) are systematic sources of information, installed in general/specialized oncology hospitals, with the aim of collecting data regarding the diagnosis, treatment, and monitoring of patients treated in these institutions. Objective: To analyze the epi...

Descripción completa

Detalles Bibliográficos
Autores: Lopes-Júnior, Luís Carlos, Grippa, Wesley Rocha
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:Brasil
Institución:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
Repositorio:Revista Brasileira de Cancerologia (Online)
Idioma:portugués
inglés
español
OAI Identifier:oai:rbc.inca.gov.br:article/4920
Acceso en línea:https://rbc.inca.gov.br/index.php/revista/article/view/4920
Access Level:acceso abierto
Palabra clave:Oncologia/tendências
Neoplasias da Próstata/epidemiologia
Epidemiologia/tendências
Saúde do Homem
Registros Hospitalares
Oncology/trends
Prostate Neoplasms/epidemiology
Epidemiology/trends
Men's Health
Hospital Records
Oncología/tendencias
Neoplasias de la Próstata/epidemiología
Epidemiología/tendencias
Salud del Hombre
Registros de Hospitales
Descripción
Sumario:Introduction: Hospital-based Cancer Registries (HCR) are systematic sources of information, installed in general/specialized oncology hospitals, with the aim of collecting data regarding the diagnosis, treatment, and monitoring of patients treated in these institutions. Objective: To analyze the epidemiological profile of patients with prostate cancer being followed up in the Oncology Care Network (OCN) of a state in southeastern Brazil. Method: Descriptive hospital-based study. Secondary data were obtained via tumor registration forms from the HCR of the entire State OCN (2000-2020). The sample was stratified between analytical and non-analytical cases and the groups compared using Student’s t-test and Pearson’s chi-square test. Additionally, a binary logistic regression was conducted. Results: We retrieved 13,519 records of prostate neoplasms from 2000-2020, where 9,838 were analytical cases and 3,681 were non-analytical. The present historical series showed an increasing trend (p<0.001). The mean age of patients was 69 years. In addition, 67.91% were referred by the SUS, 95.74% had only one primary tumor, and the tumor was classified as adenocarcinoma in 98% of the records. The first treatment received at the hospital was surgery in 23.68%, followed by hormone therapy in 21.01% of the cases. The variables ‘source of referral’ (X²(1)=18.27;p<0.001) and ‘previous diagnosis and treatment’ (X²(3)=1516.83;p<0.001) were predictors for the variable ‘type of case’ (analytical and non-analytical). Conclusion: There was a growing trend in the number of prostate cancer cases over the years in the state, with a tropism for elderly, married men with low educational levels and non-analytical cases.